Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by cancer cells and, when exposed to light, become active and kill the cancer cells. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have basal cell skin cancer.

Timeline

Start

2000-01

Primary completion

2006-12

Completion

2007-01

Drugs

Indications